Revenue: The sum of all revenue fields included for a company's operating activities.
Poniard Pharmaceuticals Inc. (PARD) Revenue data is not available.
| Income Statement Financials | |
|
Revenue |
-- |
$-30.05M |
|
-- |
|
-- |
|
$25.11M |
|
$-25.11M |
|
$-4.93M |
|
$-30.05M |
|
$-30.05M |
|
$-30.05M |
|
$-27.21M |
|
$-27.21M |
|
$-30.05M |
|
$-25.11M |
|
$-22.27M |
|
1.17M |
|
1.17M |
|
$-26.40 |
|
$-26.40 |
|
| Balance Sheet Financials | |
$5.21M |
|
$0.04M |
|
$6.41M |
|
$11.64M |
|
$1.61M |
|
$1.57M |
|
$1.57M |
|
$3.19M |
|
$8.45M |
|
$2.08M |
|
$8.45M |
|
-- |
|
| Cash Flow Statement Financials | |
$-24.27M |
|
$24.02M |
|
$-14.40M |
|
$15.93M |
|
$1.28M |
|
$-14.65M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.24 |
|
-- |
|
-- |
|
0.16 |
|
0.19 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-24.22M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-322.06% |
|
-1308.08% |
|
-233.75% |
|
-271.54% |
|
-- |
|
$-20.67 |
|
$-20.72 |
|